Related Experiment Video
Updated: Jul 31, 2026
Induction and Testing of Hypoxia in Cell Culture
Published on: August 12, 2011
Use of hypoxia-regulated gene expression in tumor-specific gene therapy
1Brain Tumor Research Center, Department of Neurological Surgery, University of California, San Francisco 94143-0520, USA.
Abstract:
The presence of hypoxic cells in human solid tumors is an important factor leading to resistance to radiation therapy and chemotherapy. However, differences in the oxygen tension between normal tissues and tumors also provide the potential for designing tumor-specific gene therapy. The strategy is to selectively induce the expression of suicide genes under hypoxia and thereby preferentially kill hypoxic cells. The hypoxia-responsive vector regulates gene expression via the hypoxia-responsive element, which can be activated through the transcriptional complex hypoxia-inducible factor 1. A gene therapy that is based on hypoxia-regulated gene expression needs to consider the suicide gene, the genetic vector, the delivery method and the bystander effect. These factors pose considerable challenges for the development of a successful hypoxia-directed gene therapy, but once this has been achieved, this type of therapy in combination with traditional radiation and chemotherapy should provide an improved clinical outcome for patients with these diseases.
Insights
Hypoxic cells in tumors resist treatment. Hypoxia-directed gene therapy aims to selectively kill these resistant cells, potentially improving outcomes when combined with traditional therapies.
Area of Science:
- Oncology
- Molecular Biology
- Gene Therapy
Background:
- Hypoxic cells within solid tumors contribute significantly to resistance against radiation and chemotherapy.
- Tumor hypoxia presents a unique therapeutic target due to differential oxygen tension compared to normal tissues.
Purpose of the Study:
- To explore the potential of hypoxia-directed gene therapy for selectively targeting and eliminating hypoxic tumor cells.
- To outline the key components and challenges in developing effective hypoxia-regulated gene expression strategies for cancer treatment.
Main Methods:
- Utilizing hypoxia-responsive vectors to control suicide gene expression specifically in low-oxygen tumor environments.
- Leveraging the hypoxia-inducible factor 1 (HIF-1) transcriptional complex to activate gene expression under hypoxic conditions.
Main Results:
- The strategy focuses on selective induction of suicide genes in hypoxic cells, leading to preferential cell killing.
- Development requires careful consideration of suicide gene choice, vector design, delivery methods, and the bystander effect.
Conclusions:
- Hypoxia-directed gene therapy offers a promising approach to overcome treatment resistance in solid tumors.
- Successful implementation, addressing current challenges, could significantly enhance clinical outcomes when integrated with conventional therapies.
Related Concept Videos
00:59Gene Therapy
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
01:24Regulation of Angiogenesis and Blood Supply
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...